J&J in talks to acquire Protagonist Therapeutics
Johnson & Johnson (J&J) is in discussions to purchase Protagonist Therapeutics, a move that would enhance their current…
Johnson & Johnson ordered to pay $966 million after jury finds company liable in talc cancer case
In this photo illustration, a container of Johnson’s baby powder made by Johnson and Johnson sits on a…
Johnson & Johnson’s Shareholder Supremacy In Healthcare
IRVINE, CALIFORNIA – OCTOBER 17: The Johnson & Johnson logo is displayed at company offices on October 17,…
Johnson & Johnson (JNJ) Surpasses Market Returns: Some Facts Worth Knowing
In the latest close session, Johnson & Johnson (JNJ) was up +1.11% at $179.71. This change outpaced the…
Why the crazy spending of this AI boom isn’t like the dot-com bubble
If I hear one more hedge fund oligarch on television tell me that the data center buildout/artificial intelligence…
Jim Cramer’s top 10 things to watch in the stock market Friday
My top 10 things to watch Friday, Sept. 26 1. The S & P 500 opened higher this…
Tylenol’s 70-year history: From kids’ drug to political controversy
Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT…
Does Online Ketamine Therapy Work? Safety Questions About Mental Health Trend
At first glance, it seems no substance better assuages the anxieties of our accelerationist era than ketamine. The…
Look for unloved stocks in areas such as health care, banking before Fed cuts rates
(PRO Views are exclusive to PRO subscribers, giving them insight on the news of the day direct from…
5 things to know before the stock market opens Monday
This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Here are five key things…